Yoichi Ozawa Selected Research

Yoichi Ozawa Research Topics

11	Neoplasms (Cancer) 01/2022 - 11/2002
4	Hypoxia (Hypoxemia) 01/2021 - 04/2012
2	Vascular Remodeling 01/2023 - 10/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 04/2017
2	Neoplasm Metastasis (Metastasis) 12/2017 - 10/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Polyps 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Vascular Tissue Neoplasms 12/2017
1	Breast Neoplasms (Breast Cancer) 10/2014
1	Glioma (Gliomas) 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 11/2002

4	lenvatinibIBA 01/2022 - 04/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2018
2	eribulin FDA Link 01/2023 - 10/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2014
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2017 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 04/2012
1	AntibodiesIBA 01/2022
1	CREB-Binding ProteinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CateninsIBA 01/2021
1	NivolumabIBA 12/2018
1	Angiogenesis InhibitorsIBA 12/2018
1	Sorafenib (BAY 43-9006)FDA Link 12/2018
1	Liposomes (Liposome)IBA 12/2017
1	TOR Serine-Threonine KinasesIBA 04/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2017
1	Everolimus FDA Link 04/2017
1	TubulinIBA 10/2014
1	Capecitabine (Xeloda)FDA Link 10/2014
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 10/2014
1	Transcription Factors (Transcription Factor)IBA 10/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2012
1	SulfonamidesIBA 05/2012
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 05/2012
1	Hypoxia-Inducible Factor 1IBA 04/2012
1	ER-400583-00IBA 04/2012
1	N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamideIBA 11/2002